Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

This dual approach is designed to target remaining cancer cells aggressively, with radiation therapy administered five days per week while patients simultaneously take daily oral chemotherapy ...

Telix Pharmaceuticals Ltd.’s glioblastoma theranostic, TLX-101, is showing promising overall survival in a phase II trial in ...

Univ. of Miami Sylvester Comprehensive Cancer Ctr., Miami, FL.

In a recent study published in Small, researchers at the University of Michigan developed nanodiscs designed to target ...

The FDA approved a pilot study for Alpha DaRT, targeting recurrent glioblastoma with alpha-radiation therapy. Alpha DaRT uses radium-224 to deliver focused radiation to tumors, sparing healthy tissue.